Assenagon Asset Management S.A. Neuronetics, Inc. Transaction History

Assenagon Asset Management S.A.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$0.73 - $2.0 $7,133 - $19,544	-9,772 Reduced 7.2%	125,974 $95,000
Q2 2024 Jul 18, 2024	BUY	$1.73 - $4.81 $90,738 - $252,284	52,450 Added 62.97%	135,746 $244,000
Q1 2024 Apr 24, 2024	SELL	$2.68 - $4.8 $7,680 - $13,756	-2,866 Reduced 3.33%	83,296 $396,000
Q4 2023 Jan 17, 2024	SELL	$1.05 - $2.9 $183,199 - $505,980	-174,476 Reduced 66.94%	86,162 $249,000
Q3 2023 Nov 06, 2023	SELL	$1.29 - $2.22 $1,548 - $2,664	-1,200 Reduced 0.46%	260,638 $351,000
Q3 2022 Oct 27, 2022	BUY	$2.35 - $4.66 $615,319 - $1.22 Million	261,838 New	261,838 $833,000
Q2 2022 Jul 27, 2022	SELL	$2.09 - $3.71 $39,292 - $69,748	-18,800 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$2.84 - $4.52 $53,392 - $84,975	18,800 New	18,800 $57,000
Q4 2021 Feb 01, 2022	SELL	$3.87 - $6.59 $338,257 - $575,998	-87,405 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$6.22 - $15.54 $1.23 Million - $3.08 Million	-198,459 Reduced 69.42%	87,405 $573,000
Q2 2021 Jul 15, 2021	BUY	$10.15 - $17.25 $2.9 Million - $4.93 Million	285,864 New	285,864 $4.58 Million

13M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $65.9M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.